Efficacy and safety of alirocumab in children and adolescents with heterozygous familial hypercholesterolaemia inadequately controlled with statins

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSANTOS, R.
dc.contributor.authorWIEGMAN, A.
dc.contributor.authorCAPRIO, S.
dc.contributor.authorCARIOU, B.
dc.contributor.authorAVERNA, M.
dc.contributor.authorPOULOUIN, Y.
dc.contributor.authorSCEMAMA, M.
dc.contributor.authorMANVELIAN, G.
dc.contributor.authorGARON, G.
dc.contributor.authorDANIELS, S.
dc.date.accessioned2024-03-08T15:01:12Z
dc.date.available2024-03-08T15:01:12Z
dc.date.issued2023
dc.description.conferencedateAUG 25-28, 2023
dc.description.conferencelocalAmsterdam, NETHERLANDS
dc.description.conferencenameAnnual Meeting of the European-Society-of-Cardiology (ESC)
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.sponsorshipSanofi
dc.identifier.citationEUROPEAN HEART JOURNAL, v.44, suppl.2, 2023
dc.identifier.eissn1522-9645
dc.identifier.issn0195-668X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/58415
dc.language.isoeng
dc.publisherOXFORD UNIV PRESSeng
dc.relation.ispartofEuropean Heart Journal
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright OXFORD UNIV PRESSeng
dc.subject.wosCardiac & Cardiovascular Systemseng
dc.titleEfficacy and safety of alirocumab in children and adolescents with heterozygous familial hypercholesterolaemia inadequately controlled with statinseng
dc.typeconferenceObjecteng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryHolanda
hcfmusp.affiliation.countryCanadá
hcfmusp.affiliation.countryisonl
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisoca
hcfmusp.author.externalWIEGMAN, A.:Amsterdam UMC, Dept Paediat, Amsterdam, Netherlands
hcfmusp.author.externalCAPRIO, S.:Yale Pediat Endocrinol, New Haven, CT USA
hcfmusp.author.externalCARIOU, B.:Univ Nantes, Inst thorax, Nantes, France
hcfmusp.author.externalAVERNA, M.:Univ Palermo, Internal Med & Med Specialties PROMISE, Palermo, Italy
hcfmusp.author.externalPOULOUIN, Y.:IT & M Stats, Paris, France
hcfmusp.author.externalSCEMAMA, M.:Sanofi, Chilly Mazarin, France
hcfmusp.author.externalMANVELIAN, G.:Regeneron Pharmaceut Inc, Tarrytown, NY USA
hcfmusp.author.externalGARON, G.:Sanofi, N York, ON, Canada
hcfmusp.author.externalDANIELS, S.:Univ Colorado, Sch Med, Aurora, CO USA
hcfmusp.contributor.author-fmusphcRAUL DIAS DOS SANTOS FILHO
hcfmusp.description.issuesuppl 2
hcfmusp.description.volume44
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:001115619404457
hcfmusp.publisher.cityOXFORDeng
hcfmusp.publisher.countryENGLANDeng
relation.isAuthorOfPublication342e0234-2bff-4c3b-a782-40e80d798912
relation.isAuthorOfPublication.latestForDiscovery342e0234-2bff-4c3b-a782-40e80d798912
Arquivos